Polycystic ovary syndrome and mental health: A review

Obstetrical and Gynecological Survey

Volumn 61, Issue 11, 2006, Pages 723-732

  Himelein, Melissa J ^a,b,c   Thatcher, Samuel S ^b,c  

^a UNIVERSITY OF NORTH CAROLINA AT ASHEVILLE   (United States)

^b Center for Applied Reproductive Science   (United States)

^c Center for Applied Reproductive Science   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; ORAL CONTRACEPTIVE AGENT; SPIRONOLACTONE; VALPROIC ACID;

ACNE; ANXIETY; BIPOLAR DISORDER; CLINICAL PRACTICE; DEPRESSION; EATING DISORDER; EXERCISE; HIRSUTISM; HUMAN; LIFE SATISFACTION; MEDICAL LITERATURE; MEDICAL SPECIALIST; MENTAL HEALTH; OBESITY; OVARY POLYCYSTIC DISEASE; PHYSICIAN; PSYCHOTHERAPY; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SEXUAL SATISFACTION;

AFFECTIVE SYMPTOMS; BODY IMAGE; FEMALE; HUMANS; INFERTILITY, FEMALE; MENTAL HEALTH; OBESITY; PERSONAL SATISFACTION; POLYCYSTIC OVARY SYNDROME; QUALITY OF LIFE; SELF CONCEPT; SEXUALITY;

EID: 33750444610     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ogx.0000243772.33357.84     Document Type: Review

References (82)

1. Lane DE. Polycystic ovary syndrome and its differential diagnosis. Obstet Gynecol Surv 2006;61:125-135.
2. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
3. Elsenbruch S, Hahn S, Kowalsky D, et al. Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:5801-5807.
4. Weiner CL, Primeau M, Ehrmann DA. Androgens and mood dysfunction in women: comparison of women with polycystic ovarian syndrome to healthy controls. Psychosom Med 2004;66:356-362.
5. Himelein MJ, Thatcher SS. Depression and body image among women with polycystic ovary syndrome. J Health Psychol. In press.
6. Hollinrake EM, Abreu A, Sparks A. Increased risk of depression in women with polycystic ovary syndrome. Proceedings of the 61st Annual Meeting of the American Society for Reproductive Medicine, Oct 15-19, 2005, Montreal, Canada.
7. McCook JG. The influence of hyperandrogenism, obesity and infertility on the psychosocial health and well-being of women with polycystic ovary syndrome [Dissertation]. Ann Arbor, MI: University of Michigan, 2002.
8. Keegan A, Liao LM, Boyle M. 'Hirsutism': a psychological analysis. J Health Psychol 2003;8:327-345.
9. Rasgon NL, Rao RC, Hwang S, et al. Depression in women with polycystic ovary syndrome: clinical and biochemical correlates. J Affect Disord 2003;74:299-304.
10. Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745-2749.
11. Stunkard AJ, Faith MS, Allison KC. Depression and obesity. Biol Psychiatry 2003;54:330-337.
12. Derogatis LR. SCL-90-R. Administration, Scoring and Procedures Manual. Baltimore: Clinical Psychometric Research, 1983.
13. Elsenbruch S, Benson S, Hahn S, et al. Determinants of emotional distress in women with polycystic ovary syndrome. Hum Reprod 2006;21:1092-1099.
14. Sonino N, Fava GA, Mani E, et al. Quality of life of hirsute women. Postgrad Med J 1993;69:186-189.
15. Kitzinger C, Willmott J. 'The thief of womanhood': women's experience of polycystic ovarian syndrome. Soc Sci Med 2002;54:349-361.
16. Stice E, Hayward C, Cameron RP, et al. Body-image and eating disturbances predict onset of depression among female adolescents: a longitudinal study. J Abnorm Psychol 2000;109:438-444.
17. Seiffge-Krenke I, Stemmler M. Factors contributing to gender differences in depressive symptoms: a test of three developmental models. J Youth Adolescence 2002;31:405-17.
18. Hashimoto DM, Schmid J, Martins FM, et al. The impact of the weight status on subjective symptomatology of the polycystic ovary syndrome: a cross-cultural comparison between Brazilian and Austrian women. Anthropol Anz 2003;61:297-310.
19. Polivy J, Herman CP. Causes of eating disorders. Annu Rev Psychol 2002;53:187-213.
20. McCluskey S, Evans C, Lacey JH, et al. Polycystic ovaries and bulimia. Fertil Steril 1991;55:287-291.
21. Jahanfar S, Eden JA, Nguyen TV. Bulimia nervosa and the polycystic ovary syndrome. Gynecol Endocrinol 1995;9:113-117.
22. Raphael FJ, Rodin DA, Peattie A, et al. Ovarian morphology and insulin sensitivity in women with bulimia nervosa. Clin Endocrinol 1995;43:451-455.
23. Morgan JF, McCluskey SE, Brunton JN, et al. Polycystic ovarian morphology and bulimia nervosa: a 9-year follow-up study. Fertil Steril 2002;77:928-931.
24. Michelmore KF, Balen AH, Dunger DB. Polycystic ovaries and eating disorders: are they related? Hum Reprod 2001;16:765-769.
25. Michelmore KF, Balen AH, Dunger DB, et al. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol (Oxf) 1999;51:779-786.
26. Hirschberg AL, Naessen S, Stridsberg M, et al. Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome. Gynecol Endocrinol 2004;19:79-87.
27. Hahn S, Janssen OE, Tan S, et al. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrinol 2005;153:853-860.
28. Trent ME, Rich M, Austin SB, et al. Fertility concerns and sexual behavior in adolescent girls with polycystic ovary syndrome: implications for quality of life. J Pediatr Adolesc Gynecol 2003;16:33-37.
29. Conaglen HM, Conaglen JV. Sexual desire in women presenting for antiandrogen therapy. J Sex Marital Ther 2003;29:255-267.
30. Cronin L, Guyatt G, Griffith L, et al. Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab 1998;83:1976-1987.
31. Guyatt G, Weaver B, Cronin L, et al. Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated. J Clin Epidemiol 2004;57:1279-1287.
32. Jones GL, Benes K, Clark TL, et al. The Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (PCOSQ): a validation. Hum Reprod 2004;19:371-377.
33. Coffey S, Bano G, Mason HD. Health-related quality of life in women with polycystic ovary syndrome: a comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36). Gynecol Endocrinol 2006;22:80-86.
34. McCook JG, Reame NE, Thatcher SS. Health-related quality of life issues in women with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs 2005;34:12-20.
35. Schmid J, Kirchengast S, Vytiska-Binstorfer E, et al. Infertility caused by PCOS-health-related quality of life among Austrian and Moslem immigrant women in Austria. Hum Reprod 2004;19:2251-2257.
36. Ware JE Jr, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 1992;30:473-483.
37. Trent ME, Rich M, Austin SB, et al. Quality of life in adolescent girls with polycystic ovary syndrome. Arch Pediatr Adolesc Med 2002;156:556-560.
38. Trent M, Austin SB, Rich M, et al. Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life. Ambul Pediatr 2005;5:107-111.
39. Modell E, Goldstein D, Reyes FI. Endocrine and behavioral responses to psychological stress in hyperandrogenic women. Fertil Steril 1990;53:454-459.
40. Gallinelli A, Matteo ML, Volpe A, et al. Autonomic and neuroendocrine responses to stress in patients with functional hypothalamic secondary amenorrhea. Fertil Steril 2000;73:812-816.
41. O'Donovan C, Kusumakar V, Graves GR, et al. Menstrual abnormalities and polycystic ovary syndrome in women taking valproate for bipolar mood disorder. J Clin Psychiatry 2002;63:322-330.
42. Joffe H, Hall JE, Cohen LS, et al. A putative relationship between valproic acid and polycystic ovarian syndrome: implications for treatment of women with seizure and bipolar disorders. Harv Rev Psychiatry 2003;11:99-108.
43. Rasgon N. The relationship between polycystic ovary syndrome and antiepileptic drugs: a review of the evidence. J Clin Psychopharmacol 2004;24:322-334.
44. Ferin M, Morrell M, Xiao E, et al. Endocrine and metabolic responses to long-term monotherapy with the antiepileptic drug valproate in the normally cycling rhesus monkey. J Clin Endocrinol Metab 2003;88:2908-2915.
45. Nelson-DeGrave VL, Wickenheisser JK, Cockrell JE, et al. Valproate potentiates androgen biosynthesis in human ovarian theca cells. Endocrinology 2004;145:799-808.
46. Rasgon NL, Altshuler LL, Fairbanks L, et al. Reproductive function and risk for PCOS in women treated for bipolar disorder. Bipolar Disord 2005;7:246-259.
47. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-613.
48. Lowe B, Kroenke K, Herzog W, et al. Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire (PHQ-9). J Affect Disord 2004;81:61-66.
49. Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care 2003;41:1284-1292.
50. Lowe B, Kroenke K, Grafe K. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res 2005;58:163-171.
51. Pignone MP, Gaynes BN, Rushton JL, et al. Screening for depression in adults: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002;136:765-776.
52. Kroenke K. Depression screening is not enough. Ann Intern Med 2001;134:418-420.
53. Pampallona S, Bollini P, Tibaldi G, et al. Combined pharmacotherapy and psychological treatment for depression: a systematic review. Arch Gen Psychiatry 2004;61:714-719.
54. Morgan JF, Reid F, Lacey JH. The SCOFF questionnaire: assessment of a new screening tool for eating disorders. BMJ 1999;319:1467-1468.
55. Luck AJ, Morgan JF, Reid F, et al. The SCOFF questionnaire and clinical interview for eating disorders in general practice: comparative study. BMJ 2002;325:755-756.
56. Pritts SD, Susman J. Diagnosis of eating disorders in primary care. Am Fam Physician 2003;67:297-304.
57. Thompson JK, Heinberg LJ, Altabe M, et al. Exacting Beauty: Theory, Assessment, and Treatment of Body Image Disturbance. Washington, DC: American Psychological Association, 1999.
58. Clayton WJ, Lipton M, Elford J, et al. A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome. Br J Dermatol 2005;152:986-992.
59. Murray CD, Rhodes K. 'Nobody likes damaged goods': the experience of adult visible acne. Br J Health Psychol 2005;10:183-202.
60. Archer JS, Chang RJ. Hirsutism and acne in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2004;18:737-754.
61. Wing RR, Hill JO. Successful weight loss maintenance. Annu Rev Nutr 2001;21:323-341.
62. Curioni CC, Lourenco PM. Long-term weight loss after diet and exercise: a systematic review. Int J Obes (Lond) 2005;29:1168-1174.
63. Hill JO, Thompson H, Wyatt H. Weight maintenance: what's missing? J Am Diet Assoc 2005;105(suppl 1):S63-S66.
64. Ernsberger P, Koletsky RJ. Biomedical rationale for a wellness approach to obesity: an alternative to a focus on weight loss. J Soc Issues 1999;55:221-260.
65. Haslam DW, James WP. Obesity. Lancet 2005;366:1197-1209.
66. Bish CL, Blanck HM, Serdula MK, et al. Diet and physical activity behaviors among Americans trying to lose weight: 2000 Behavioral Risk Factor Surveillance System. Obes Res 2005;13:596-607.
67. National Institutes of Health. The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Bethesda, MD: North American Association for the Study of Obesity, National Heart, Lung, and Blood Institute; 2000. NIH publication 00-4084. Available at: www.nhlbi.nih.gov/guidelines/obesity/practgde.htm. Accessed June 15, 2006.
68. Orzano AJ, Scott JG. Diagnosis and treatment of obesity in adults: an applied evidence-based review. J Am Board Fam Pract 2004;17:359-369.
69. Norman RJ, Davies MJ, Lord J, et al. The role of lifestyle modification in polycystic ovary syndrome. Trends Endocrinol Metab 2002;13:251-257.
70. Moran L, Norman RJ. Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 2004;18:719-736.
71. Stamets K, Taylor DS, Kunselman A, et al. A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome. Fertil Steril 2004;81:630-637.
72. Klein S, Sheard NF, Pi-Sunyer X, et al. Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Am J Clin Nutr 2004;80:257-263.
73. Tsai AG, Wadden TA. Systematic review: an evaluation of major commercial weight loss programs in the United States. Ann Intern Med 2005;142:56-66.
74. Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care 2002;25:2165-2171.
75. Hoeger KM, Kochman L, Wixom N, et al. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study. Fertil Steril 2004;82:421-429.
76. Bacon L, Stern JS, Van Loan MD, et al. Size acceptance and intuitive eating improve health for obese, female chronic dieters. J Am Diet Assoc 2005;105:929-936.
77. DiLorenzo TM, Bargman EP, Stucky-Ropp R, et al. Long-term effects of aerobic exercise on psychological outcomes. Prev Med 1999;28:75-85.
78. Penedo FJ, Dahn JR. Exercise and well-being: a review of mental and physical health benefits associated with physical activity. Curr Opin Psychiatry 2005;18:189-193.
79. Williams PA, Cash TF. Effects of a circuit weight training program on the body images of college students. Int J Eat Disord 2001;30:75-82.
80. Estabrooks PA, Glasgow RE, Dzewaltowski DA. Physical activity promotion through primary care. JAMA 2003;289:2913-2916.
81. Annesi JJ. Relationship of social cognitive theory factors to exercise maintenance in adults. Percept Mot Skills 2004;99:142-148.
82. Hahn S, Benson S, Elsenbruch S, et al. Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality. Hum Reprod E-pub 2006 Mar 20.